A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast

Abstract

Replicative aging of Saccharomyces cerevisiae is an established model system for eukaryotic cellular aging. A limitation in yeast lifespan studies has been the difficulty of separating old cells from young cells in large quantities. We engineered a new platform, the Miniature-chemostat Aging Device (MAD), that enables purification of aged cells at sufficient quantities for genomic and biochemical characterization of aging yeast populations. Using MAD, we measured DNA accessibility and gene expression changes in aging cells. Our data highlight an intimate connection between aging, growth rate, and stress. Stress-independent genes that change with age are highly enriched for targets of the signal recognition particle (SRP). Combining MAD with an improved ATAC-Seq method, we find that increasing proteasome activity reduces rDNA instability usually observed in aging cells, and contrary to published findings, provide evidence that global nucleosome occupancy does not change significantly with age.

Data availability

We've included all processed data in easily accessible tables.Sequencing data have been deposited in GEO under accession codes GSE118581

The following data sets were generated
    1. Hendrickson DG
    2. Soifer I
    (2018) Genomic analysis of aging yeast
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE118581).

Article and author information

Author details

  1. David G Hendrickson

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    David G Hendrickson, Is affiliated with Calico Life Sciences. There are no other competing interests.
  2. Ilya Soifer

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Ilya Soifer, Is affiliated with Calico Life Sciences. There are no other competing interests.
  3. Bernd J Wranik

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Bernd J Wranik, Is affiliated with Calico Life Sciences. There are no other competing interests.
  4. Griffin Kim

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Griffin Kim, Is affiliated with Calico Life Sciences. There are no other competing interests.
  5. Michael Robles

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Michael Robles, Is affiliated with Calico Life Sciences. There are no other competing interests.
  6. Patrick A Gibney

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Patrick A Gibney, Is affiliated with Calico Life Sciences. There are no other competing interests.
  7. R Scott McIsaac

    Calico Life Sciences, LLC, South San Francisco, United States
    For correspondence
    rsm@calicolabs.com
    Competing interests
    R Scott McIsaac, Is affiliated with Calico Life Sciences. There are no other competing interests.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5339-6032

Funding

The authors declare that there was no funding for this work.

Copyright

© 2018, Hendrickson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 13,382
    views
  • 1,385
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David G Hendrickson
  2. Ilya Soifer
  3. Bernd J Wranik
  4. Griffin Kim
  5. Michael Robles
  6. Patrick A Gibney
  7. R Scott McIsaac
(2018)
A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast
eLife 7:e39911.
https://doi.org/10.7554/eLife.39911

Share this article

https://doi.org/10.7554/eLife.39911

Further reading

    1. Computational and Systems Biology
    Masaaki Uematsu, Jeremy M Baskin
    Tools and Resources

    Plasmid construction is central to life science research, and sequence verification is arguably its costliest step. Long-read sequencing has emerged as a competitor to Sanger sequencing, with the principal benefit that whole plasmids can be sequenced in a single run. Nevertheless, the current cost of nanopore sequencing is still prohibitive for routine sequencing during plasmid construction. We develop a computational approach termed Simple Algorithm for Very Efficient Multiplexing of Oxford Nanopore Experiments for You (SAVEMONEY) that guides researchers to mix multiple plasmids and subsequently computationally de-mixes the resultant sequences. SAVEMONEY defines optimal mixtures in a pre-survey step, and following sequencing, executes a post-analysis workflow involving sequence classification, alignment, and consensus determination. By using Bayesian analysis with prior probability of expected plasmid construction error rate, high-confidence sequences can be obtained for each plasmid in the mixture. Plasmids differing by as little as two bases can be mixed as a single sample for nanopore sequencing, and routine multiplexing of even six plasmids per 180 reads can still maintain high accuracy of consensus sequencing. SAVEMONEY should further democratize whole-plasmid sequencing by nanopore and related technologies, driving down the effective cost of whole-plasmid sequencing to lower than that of a single Sanger sequencing run.

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    Shinichi Kawaguchi, Xin Xu ... Toshie Kai
    Research Article

    Protein–protein interactions are fundamental to understanding the molecular functions and regulation of proteins. Despite the availability of extensive databases, many interactions remain uncharacterized due to the labor-intensive nature of experimental validation. In this study, we utilized the AlphaFold2 program to predict interactions among proteins localized in the nuage, a germline-specific non-membrane organelle essential for piRNA biogenesis in Drosophila. We screened 20 nuage proteins for 1:1 interactions and predicted dimer structures. Among these, five represented novel interaction candidates. Three pairs, including Spn-E_Squ, were verified by co-immunoprecipitation. Disruption of the salt bridges at the Spn-E_Squ interface confirmed their functional importance, underscoring the predictive model’s accuracy. We extended our analysis to include interactions between three representative nuage components—Vas, Squ, and Tej—and approximately 430 oogenesis-related proteins. Co-immunoprecipitation verified interactions for three pairs: Mei-W68_Squ, CSN3_Squ, and Pka-C1_Tej. Furthermore, we screened the majority of Drosophila proteins (~12,000) for potential interaction with the Piwi protein, a central player in the piRNA pathway, identifying 164 pairs as potential binding partners. This in silico approach not only efficiently identifies potential interaction partners but also significantly bridges the gap by facilitating the integration of bioinformatics and experimental biology.